uric acid has been researched along with adenosine in 109 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (39.45) | 18.7374 |
| 1990's | 25 (22.94) | 18.2507 |
| 2000's | 20 (18.35) | 29.6817 |
| 2010's | 16 (14.68) | 24.3611 |
| 2020's | 5 (4.59) | 2.80 |
| Authors | Studies |
|---|---|
| Bearne, SL; Lunn, FA; Roy, AC | 1 |
| Berlin, RD; Oliver, JM | 1 |
| Balis, ME | 1 |
| Coleman, MS; Daoud, A; Donofrio, J; Dyminski, J; Hutton, JJ; Lampkin, B | 1 |
| Akiyoshi, H; Fujii, S; Ito, T; Sato, F | 1 |
| Law, JS; Rhoads, AR; Watanabe, K; West, WL; Williams, EF | 1 |
| Hashimoto, M; Matsunaga, Y; Miyazaki, H | 1 |
| Lohmann, W; Sapper, H; Schimmack, W | 1 |
| Lohmann, W; Schimmack, W | 1 |
| Camiña, F; Castro-Gago, M; Lojo, S; Rodríguez-Núñez, A; Rodríguez-Segade, S | 1 |
| Bontemps, F; Mimouni, M; Van den Berghe, G | 1 |
| Klompmaker, IJ; Pruim, J; Slooff, MJ; ten Vergert, EM; Verwer, R | 1 |
| Anania, V; De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M | 1 |
| Eklof, B; Jabs, CM; Neglen, P; Thomas, EJ | 1 |
| Barrera, CM; Dohanich, GP; Dunlap, WP; Hunter, RE | 1 |
| Becker, BF; Gerlach, E; Leipert, B; Ozçelik, T; Reinholz, N | 1 |
| Barraco, RA; Phillis, JW; Polasek, PM; Thorderson, J; Walter, GA | 1 |
| Barnard, HC; Barnard, SP; Maartens, JJ; Potgieter, GM; van Jaarsveld, H | 1 |
| O'Reagan, MH; Phillis, JW; Walter, GA | 1 |
| McCaman, MW | 1 |
| Wheeler, CP; Yudilevich, DL | 1 |
| O'Regan, MH; Phillis, JW; Walter, GA | 1 |
| Brodin, LA; Järnberg, PO; Owall, A; Sollevi, A | 1 |
| Dorigo, P; Gaion, RM; Gambarotto, L | 1 |
| Edlund, A; Fitzgerald, GA; Nowak, J; Wennmalm, A; Wennmalm, M | 1 |
| Kather, H; Waas, W; Wieland, E | 1 |
| Chu, KM; Tseng, CJ; Tung, CS; Yin, TH | 1 |
| Ishida, N; Majima, T; Sami, S; Takano, S | 1 |
| de Bree, PK; Duran, M; Fabery de Jonge, H; Wadman, SK | 1 |
| Achterberg, PW; De Jong, JW; Stroeve, RJ | 1 |
| Armiger, LC; Hollis, DG; Seelye, RN | 1 |
| Hashimoto, T; Hayakawa, T; Ikeda, T; Jamshidi, J; Masana, Y; Mogami, H; Morimoto, K | 1 |
| Ishida, N | 1 |
| McLennan, BD; Pater, A | 1 |
| Krzyzanowska, M; Niemierko, W | 1 |
| Caen, JP; Jenkins, CS; Pokutecky, J; Vainer, H | 1 |
| Green, H; Ishii, K | 1 |
| Caen, JP; Chivot, JJ; Jenkins, CS; Levy-Toledano, S; Michel, H; Rendu, F | 1 |
| Kelley, WN | 1 |
| Chheda, GB; Mittelman, A | 1 |
| Burns, RA; Buttery, PJ | 1 |
| Fredholm, BB; Lerner, U | 1 |
| Bresler, VM; Chusova, GG; Ostapenko, IA; Rebane, EN | 1 |
| Fredholm, B; Hohlbach, G; Schildberg, FW; Schoenberg, M | 1 |
| De Jong, JW; De Tombe, PP; Harmsen, E | 1 |
| Chagoya de Sánchez, V; Díaz-Muñoz, M; Glender, W; Hernández-Muñoz, R; Suárez, J; Vidrio, S; Villalobos, R; Yañez, L | 1 |
| Briske-Anderson, M; Duerre, JA | 1 |
| Hassinen, IE; Peuhkurinen, KJ; Raatikainen, MJ | 1 |
| Eklund, T; Hillered, L; Wahlberg, J | 1 |
| Lautt, WW; Li, T; Zhang, YL | 1 |
| Bardenheuer, HJ; Fabry, A; Höfling, B; Peter, K | 1 |
| Di Pierro, D; Giardina, B; Lazzarino, G; Nissinen, J; Nuutinen, M; Peuhkurinen, K; Raatikainen, P; Tavazzi, B | 1 |
| Bissbort, SH; Oosthuizen, HM; Ungerer, JP | 1 |
| Dagianti, A; Di Pierro, D; Fedele, F; Giardina, B; Lazzarino, G; Penco, M; Romano, S; Tavazzi, B | 1 |
| Gross, GJ; Mei, DA; Nithipatikom, K | 1 |
| Aguilar-Roblero, R; Chagoya de Sánchez, V; Díaz-Muñoz, M; Drucker-Colín, R; Fernández-Cancino, F; Hernández-Muñoz, R; Oksenberg, A; Rosenthal, L; Suárez, J; Vega-González, A; Vidrio, S; Villalobos, L; Yáñez, L | 1 |
| LeBlanc, MH | 1 |
| Barclay, KD; Buckley, SJ; Feng, JD; Hung, OR; Klassen, GA; Pollak, PT; Yeung, PK | 1 |
| Bardenheuer, HJ; Li, C; Martin, E; Schmidt, H; Schmidt, W; Weigand, MA | 1 |
| Jayakumar, J; Seymour, AM; Smolenski, RT; Yacoub, MH | 1 |
| Makarewicz, W; Smolenski, RT; Yacoub, MH; Zych, M | 1 |
| Gross, GJ; Lasley, RD; Mei, DA; Nithipatikom, K | 1 |
| Balogh, A; Bruckner, G; Kósa, E; Medveczky, I; Szabó, J | 1 |
| Barynov, EF; Barynova, ME; Bondarenko, NM; Hryn', VK; Syniachenko, OV | 1 |
| Bracht, A; Constantin, J; Fernandes, TR; Ishii-Iwamoto, EL; Suzuki-Kemmelmeier, F | 1 |
| Kaznowska, Z; Simmonds, HA; Smoleńska, Z; Smoleński, RT; Zarówny, D | 1 |
| Feng, JD; Yeung, PK | 1 |
| Camp, DM; Harel, E; Juneau, PL; LeWitt, PA; Loeffler, DA | 1 |
| Araki, T; Sawa, R; Suzuki, S; Yoneyama, Y | 1 |
| Bakker, SJ; Gans, RO; Heine, RJ; Teerlink, T; ter Maaten, JC; Westerhoff, HV | 1 |
| Al-Awadi, FM; Khan, I | 1 |
| Araki, T; Otsubo, Y; Sawa, R; Suzuki, S; Takeuchi, T; Yoneyama, Y | 1 |
| Ashihara, H; Crozier, A; Kato, M; Ye, CX; Zheng, XQ | 1 |
| Kapczinski, F; Lara, DR; Machado-Vieira, R; Souza, DO | 1 |
| Kawakami, Y; Makita, H; Miyamoto, K; Nishimura, M; Saito, H; Shibuya, E; Tsujino, I | 1 |
| Hidaka, Y | 1 |
| KRANEN-FIEDLER, U | 1 |
| DOBSON, RL; RATNER, AC | 1 |
| Alfaro, V; De Oca, J; Hotter, G; Jaurrieta, E; Sola, A; Xaus, C | 1 |
| Suzuki, S; Yoneyama, Y | 1 |
| Bardenheuer, HJ; Heller, AR; Koch, T; Plaschke, K; Rothermel, J; Schmeck, J; Weigand, MA; Wendel, M | 1 |
| Hatzigeorgiou, AG; Iizasa, H; Kawahara, Y; Nishikura, K; Sethupathy, P; Zinshteyn, B | 1 |
| Chintala, S; Gobe, GG; Goligorsky, MS; Patschan, D; Patschan, S | 1 |
| Oestreicher, N; Ribard, C; Scazzocchio, C | 1 |
| Jurecka, A; Kmoch, S; Krijt, J; Tylki-Szymanska, A; Zikanova, M | 1 |
| Hu, P; Li, P; Liang, QL; Luo, GA; Wang, YM; Xia, JF | 1 |
| Antunes, C; Böhmer, AE; Elisabetsky, E; Lara, DR; Porciúncula, LO; Schallenberger, C; Schmidt, AP; Souza, DO | 1 |
| Corps, CL; Crellin, D; Lodge, JP; Potts, D; Pratt, J; Shires, M; Smolenski, R | 1 |
| Docherty, SM; Iles, RK; Jones, N; Perrett, D; Tozer, AJ; Wen, X | 1 |
| Gyu Jeon, S; Kim, YK; Kim, YS; Moon, HG; Oh, SY; Song Gho, Y; Tae, YM; Zhu, Z | 1 |
| Carta, AR; Kachroo, A; Morelli, M; Schwarzschild, MA | 1 |
| Butler, K; Teng, R | 1 |
| Fujikawa, A; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Koizumi, T; Kuwayama, K; Maruyama, H; Ogura, J; Takahashi, N; Takaya, A; Terada, Y; Tsujimoto, T; Yamaguchi, H | 1 |
| Aragon-Martinez, OH; Galicia, O; Isiordia-Espinoza, MA; Martinez-Morales, F | 1 |
| Li, G; Liu, T; Xu, Y; Yang, Y; Zhang, N; Zhang, Z | 1 |
| Phechkrajang, CM; Rojsanga, P; Rukdee, N | 1 |
| Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J | 1 |
| Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M | 1 |
| Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
| Agu, RU; Kolathuru, SS; Yeung, PK | 1 |
| Bartoli, F; Carrà, G; Clerici, M | 1 |
| Bai, X; He, J; Li, T; Qiao, H; Xu, J; Ye, X; Zhang, J; Zhang, W | 1 |
| Andries, A; De Rechter, S; Janssens, P; Mekahli, D; Van Schepdael, A | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chen, Y; Ji, P; Li, T; Ma, G; Song, Z; Tang, BQ | 1 |
| Albratty, M; Alhazmi, HA; Behl, T; Chandel, P; Makeen, HA; Meraya, AM; Sehgal, A; Sikka, P; Singh, S | 1 |
| Hou, C; Li, Y; Ren, J; Sha, W; Yao, M | 1 |
| Boison, D; Daniels, SD | 1 |
8 review(s) available for uric acid and adenosine
| Article | Year |
|---|---|
Membrane transport of purine and pyrimidine bases and nucleosides in animal cells.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adenosine; Animals; Binding Sites; Binding, Competitive; Biological Transport, Active; Blood; Blood Cells; Cell Division; Cell Line; Cell Membrane; Cyclic AMP; Hypoxanthines; Intestinal Mucosa; Kinetics; Lipids; Nucleosides; Phosphorus; Purines; Pyrimidines; Structure-Activity Relationship; Temperature; Thymidine; Uric Acid; Uridine | 1975 |
Uric acid metabolism in man.
Topics: Adenine Phosphoribosyltransferase; Adenosine; Adenosine Deaminase; Animals; Cells, Cultured; Gout; Humans; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; Lesch-Nyhan Syndrome; Lymphocytes; Phosphoribosyl Pyrophosphate; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Rats; Ribose-Phosphate Pyrophosphokinase; Sex Chromosomes; Uric Acid; Xanthines | 1976 |
[Isolation of factors responsible for the immunosuppression found in tumor-bearing animals].
Topics: Adenosine; Animals; Glycoproteins; Humans; Immune Tolerance; Macrophage Activation; Macrophages; Mice; Molecular Weight; Neoplasm Proteins; Neoplasms; Nucleosides; RNA, Transfer; Uracil; Uric Acid | 1985 |
[5'-nucleotidase].
Topics: 5'-Nucleotidase; Adenosine; Erythrocytes; Humans; Lymphocytes; Muscles; Purine Nucleotides; Uric Acid | 2003 |
Pathophysiological roles for purines: adenosine, caffeine and urate.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Caffeine; Dopamine; Humans; Neuroprotective Agents; Parkinson Disease; Purines; Receptor, Adenosine A2A; Uric Acid | 2010 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression.
Topics: Adenosine; Adenosine Triphosphate; Antidepressive Agents; Depression; Humans; Male; Receptors, Purinergic; Uric Acid | 2022 |
Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence.
Topics: Adenosine; Adenosine Triphosphate; Antimanic Agents; Bipolar Disorder; Epilepsy; Humans; Hydrocortisone; Mania; Purines; Uric Acid; Valproic Acid | 2023 |
4 trial(s) available for uric acid and adenosine
| Article | Year |
|---|---|
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adult; Epinephrine; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Heart Rate; Hemodynamics; Humans; Hypoxanthine; Hypoxanthines; Inosine; Leg; Male; Regional Blood Flow; Uric Acid | 1987 |
Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis.
Topics: Adenosine; Adenosine Triphosphate; Adult; Aminoimidazole Carboxamide; Antirheumatic Agents; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Chronic Disease; Cytidine Triphosphate; Erythrocytes; Female; Guanosine Triphosphate; Humans; Hypoxanthine; Methotrexate; Middle Aged; Ribonucleotides; Uric Acid; Uridine | 1999 |
Evaluation and characterization of the effects of ticagrelor on serum and urinary uric acid in healthy volunteers.
Topics: Adenosine; Adult; Cross-Over Studies; Humans; Hyperuricemia; Hypoxanthine; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Ticagrelor; Time Factors; Uric Acid; Xanthine | 2012 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
98 other study(ies) available for uric acid and adenosine
| Article | Year |
|---|---|
Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids.
Topics: Carbon-Nitrogen Ligases; Enzyme Inhibitors; Escherichia coli; Kinetics; Methylation; Structure-Activity Relationship; Uric Acid; Xanthines | 2010 |
Purine and pyrimidine metabolism.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Ascorbic Acid; Female; Humans; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Methylene Blue; Phosphoribosyl Pyrophosphate; Purines; Pyrimidines; Ribosemonophosphates; Uric Acid | 1977 |
Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
Topics: Adenosine; Adenosine Deaminase; Bone Marrow; Deoxyadenine Nucleotides; Deoxyadenosines; Erythrocytes; Humans; Immunologic Deficiency Syndromes; Infant; Lymphocytes; Male; Nucleoside Deaminases; Uric Acid | 1978 |
Metabolism of adenine nucleotides in the rat. Studies in vivo by intravenous and intraduodenal administration, and in vitro using red and fat cells.
Topics: Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Adipose Tissue; Allantoin; Animals; Duodenum; Erythrocytes; Male; Rats; Tissue Distribution; Uric Acid | 1978 |
An application of alumina column for the assay of adenine and hypoxanthine/guanine phosphoribosyltransferase activity: simple and rapid method.
Topics: Adenine Phosphoribosyltransferase; Adenosine; Adenosine Monophosphate; Aluminum Oxide; Animals; Brain; Hypoxanthine Phosphoribosyltransferase; Liver; Methods; Pentosyltransferases; Proteins; Rats; Uric Acid; Xanthines | 1978 |
Distribution of [14C]labeled purines in the mouse. A whole body autoradiographic assessment of purine metabolism in mammals.
Topics: Adenosine; Animals; Autoradiography; Carbon Radioisotopes; Cells, Cultured; Erythrocytes; Hypoxanthines; Inosine; Male; Mice; Organ Specificity; Purines; Thymidine; Uric Acid; Uridine; Xanthines | 1978 |
Stacking interactions of nucleobases: NMR-investigations. II. Self-association of purine-and pyrimidine-derivatives.
Topics: Adenine; Adenosine; Caffeine; Chemical Phenomena; Chemistry; Cytosine; Deuterium; Hypoxanthines; Magnetic Resonance Spectroscopy; Polymers; Purines; Pyrimidines; Thermodynamics; Uracil; Uric Acid; Water | 1975 |
Association of sexual hormones with nucleobases in water: NMR-investigations.
Topics: Adenine; Adenosine; Caffeine; Chemical Phenomena; Chemistry; Cytosine; Deuterium; Estradiol; Hypoxanthines; Magnetic Resonance Spectroscopy; Purines; Pyrimidines; Testosterone; Thermodynamics; Uracil; Uric Acid; Water | 1975 |
Purine metabolites and pyrimidine bases in cerebrospinal fluid of children with simple febrile seizures.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Child, Preschool; Cytosine; Female; Guanine; Guanosine; Humans; Hypoxanthine; Hypoxanthines; Infant; Inosine; Inosine Monophosphate; Male; Purines; Pyrimidine Nucleosides; Seizures, Febrile; Thymine; Uracil; Uric Acid; Xanthine; Xanthines | 1991 |
Phosphorylation of adenosine by an exchange reaction between AMP and adenosine in anoxic hepatocytes.
Topics: Adenosine; Adenosine Monophosphate; Allantoin; Animals; Carbon Radioisotopes; Cell Hypoxia; Cell-Free System; Cells, Cultured; Cytosol; Kinetics; Liver; Male; Phosphorylation; Radioisotope Dilution Technique; Rats; Rats, Inbred Strains; Uric Acid | 1991 |
Cellular damage and early metabolic function of transplanted livers stored in Eurocollins or University of Wisconsin solution.
Topics: Adenosine; Adult; Allopurinol; Amino Acids; Bile Acids and Salts; Female; Glutathione; Humans; Hypertonic Solutions; Insulin; Liver; Liver Transplantation; Male; Middle Aged; Organ Preservation; Organ Preservation Solutions; Raffinose; Solutions; Uric Acid | 1991 |
[Cadmium-induced changes in the activity of the dopaminergic and purinergic systems and in ascorbic acid catabolism in the rat striatum].
Topics: Adenosine; Animals; Ascorbic Acid; Cadmium; Cadmium Compounds; Corpus Striatum; Dopamine; Male; Rats; Receptors, Dopamine; Receptors, Purinergic; Sulfates; Uric Acid | 1991 |
Adenosine, inosine, and hypoxanthine/xanthine measured in tissue and plasma by a luminescence method.
Topics: Adenosine; Adenosine Deaminase; Animals; Dogs; Humans; Hypoxanthine; Hypoxanthines; Inosine; Luminescent Measurements; Luminol; Pyridazines; Rabbits; Rats; Solutions; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines | 1990 |
Effects of uric acid and caffeine on A1 adenosine receptor binding in developing rat brain.
Topics: Adenosine; Aging; Animals; Binding, Competitive; Brain; Caffeine; Male; Oxonic Acid; Rats; Rats, Inbred Strains; Receptors, Purinergic; Time Factors; Uric Acid | 1990 |
Uric acid as radical scavenger and antioxidant in the heart.
Topics: Acetylcholine; Adenosine; Allopurinol; Animals; Antioxidants; Coronary Vessels; Dimethyl Sulfoxide; Free Radicals; Guinea Pigs; Heart; Hydroxides; Hydroxyl Radical; Male; Myocardium; Oxidation-Reduction; Superoxides; Uric Acid; Xanthine Oxidase | 1989 |
Adenosine, inosine, hypoxanthine, xanthine and uric acid concentrations in the cerebrospinal fluid of unanaesthetized rats.
Topics: Adenosine; Anesthesia; Animals; Hypoxanthines; Inosine; Male; Rats; Rats, Inbred Strains; Uric Acid; Xanthines | 1989 |
Purine and oxypurine production in mitochondria of ischemic and reperfused myocardium.
Topics: Adenine Nucleotides; Adenosine; Allopurinol; Animals; Hypoxanthine; Hypoxanthines; Male; Malondialdehyde; Mitochondria, Heart; Myocardial Reperfusion Injury; Purines; Rats; Rats, Inbred Strains; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines | 1989 |
Determination of rat cerebrospinal fluid concentrations of adenosine, inosine, hypoxanthine, xanthine and uric acid by high performance liquid chromatography.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Hypoxanthines; Inosine; Male; Nucleosides; Rats; Rats, Inbred Strains; Uric Acid; Xanthines | 1988 |
Uptake and metabolism of [3H]adenosine by Aplysia ganglia and by individual neurons.
Topics: Adenine Nucleotides; Adenosine; Animals; Aplysia; Chromatography, High Pressure Liquid; Cyclic AMP; Ganglia; Hypoxanthine; Hypoxanthines; Inosine; Inosine Monophosphate; Neurons; Tissue Distribution; Uric Acid | 1986 |
Transport and metabolism of adenosine in the perfused guinea-pig placenta.
Topics: Adenosine; Animals; Biological Transport; Dipyridamole; Female; Guinea Pigs; Hypoxanthine; Hypoxanthines; Inosine; Maternal-Fetal Exchange; Placenta; Pregnancy; Thioinosine; Tritium; Uric Acid | 1988 |
Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine, and uric acid release from the hypoxemic rat cerebral cortex.
Topics: Adenosine; Animals; Cerebral Cortex; Coformycin; Hypoxanthine; Hypoxanthines; Hypoxia; Inosine; Male; Pentostatin; Rats; Rats, Inbred Strains; Ribonucleosides; Uric Acid; Xanthine; Xanthines | 1988 |
Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism in fentanyl anesthetized patients with peripheral vascular disease.
Topics: Adenosine; Aged; Anesthesia, Intravenous; Coronary Circulation; Female; Fentanyl; Hemodynamics; Humans; Hypotension, Controlled; Hypoxanthines; Lactates; Male; Myocardium; Oxygen Consumption; Uric Acid; Vascular Surgical Procedures | 1988 |
A reexamination of the effects induced by adenosine and its degradation products on rat fat cell lipolysis.
Topics: Adenosine; Adenosine Deaminase; Adipose Tissue; Animals; Dose-Response Relationship, Drug; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Inosine; Lipid Mobilization; Norepinephrine; Rats; Theophylline; Uric Acid | 1988 |
Chemiluminescent determination of adenosine, inosine, and hypoxanthine/xanthine.
Topics: Adenosine; Adipose Tissue; Chromatography, High Pressure Liquid; Humans; Hydrogen Peroxide; Hypoxanthine; Hypoxanthines; Inosine; Luminescent Measurements; Oxidation-Reduction; Uric Acid; Xanthine; Xanthines | 1987 |
Adenosine in hemorrhagic shock: possible role in attenuating sympathetic activation.
Topics: Adenosine; Animals; Blood Pressure; Epinephrine; Heart Rate; Male; Norepinephrine; Rabbits; Shock, Hemorrhagic; Uric Acid | 1987 |
Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascitic fluids of mice. 2. 1-Methyladenosine isolated from cancer ascitic fluids enhances Listeria infection in mice.
Topics: Adenosine; Animals; Ascitic Fluid; Carcinoma, Ehrlich Tumor; Immunosuppressive Agents; Listeriosis; Liver; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Peritoneal Cavity; Phagocytosis; Pseudouridine; Uracil; Uric Acid | 1986 |
Diagnosis of inherited adenylosuccinase deficiency by thin-layer chromatography of urinary imidazoles and by automated cation exchange column chromatography of purines.
Topics: Adenosine; Adenylosuccinate Lyase; Adolescent; Aminoimidazole Carboxamide; Autoanalysis; Child; Chromatography, Ion Exchange; Chromatography, Thin Layer; Erythrocytes; Female; Humans; Imidazoles; Infant; Lyases; Male; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Ribonucleosides; Uric Acid | 1986 |
Myocardial adenosine cycling rates during normoxia and under conditions of stimulated purine release.
Topics: Acetates; Acetic Acid; Adenosine; Animals; In Vitro Techniques; Inosine; Male; Myocardium; Oxygen; Purines; Rats; Rats, Inbred Strains; Stimulation, Chemical; Tubercidin; Uric Acid | 1986 |
Regional variations in the "adenine/oxypurine" pool of the heart in normoxia and oxygen deficiency.
Topics: Adenine Nucleotides; Adenosine; Animals; Chromatography, High Pressure Liquid; Dogs; Energy Metabolism; Female; Hypoxanthine; Hypoxanthines; Hypoxia; Inosine Monophosphate; Male; Myocardium; NAD; Uric Acid; Xanthine; Xanthines | 1986 |
[Cerebrospinal fluid concentrations of creatinine and purine metabolites determined by high performance liquid chromatography: preliminary report on head injury and stroke patients].
Topics: Adenosine; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Craniocerebral Trauma; Creatinine; Humans; Hypoxanthine; Hypoxanthines; Inosine; Uric Acid | 1987 |
The enzymic phosphorylation of N6-(delta 2-isopentenyl) adenosine in chick liver homogenates.
Topics: Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Alkenes; Animals; Carbon Radioisotopes; Chickens; Hydrogen-Ion Concentration; Kidney; Kinetics; Liver; Magnesium; Phosphotransferases; Rabbits; Sarcoma 180; Uric Acid | 1973 |
Separation and determination of nanomole amounts of some purines, uric acid and uric acid riboside by two-dimensional paper chromatography.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Amino Acids; Chromatography, Paper; Hypoxanthines; Methods; Microchemistry; Nucleosides; Purines; Uric Acid; Xanthines | 1974 |
Inhibition of adenosine uptake by platelets.
Topics: Adenine; Adenosine; Blood Platelets; Buffers; Carbon Isotopes; Dipyridamole; Drug Synergism; Humans; Hypoxanthines; In Vitro Techniques; Inosine; Uric Acid | 1972 |
On the existence of a guanine nucleotide trap, the role of adenosine kinase and a possible cause of excessive purine production in mammalian cells.
Topics: Adenosine; Adenosine Monophosphate; Animals; Cell Line; Fibroblasts; Gout; Guanine; Guanine Nucleotides; HeLa Cells; Humans; In Vitro Techniques; Inosine Nucleotides; Mice; Phosphotransferases; Purines; Uric Acid; Xanthines | 1972 |
Adenosine metabolism in platelets and plasma.
Topics: Adenosine; Adenosine Diphosphate; Animals; Anticoagulants; Binding Sites; Blood Cell Count; Blood Platelets; Buffers; Carbon Radioisotopes; Centrifugation, Density Gradient; Depression, Chemical; Dipyridamole; Guinea Pigs; Humans; Hypoxanthines; Inosine; Lithium; Platelet Adhesiveness; Prostaglandins; Rabbits; Rats; Receptors, Drug; Species Specificity; Temperature; Time Factors; Uric Acid | 1973 |
Pathophysiology of purine metabolism in man.
Topics: Adenosine; Alkaline Phosphatase; Amidinotransferases; Amidohydrolases; Glomerular Filtration Rate; Glucosephosphate Dehydrogenase; Gout; Guanine Nucleotides; Humans; Hypoxanthines; Kinetics; Lesch-Nyhan Syndrome; Pentosephosphates; Pentosyltransferases; Purine-Pyrimidine Metabolism, Inborn Errors; Purines; Ribose; Uric Acid; Xanthine Oxidase; Xanthines | 1974 |
N 6 -( 2 -isopentenyl)adenosine metabolism in man.
Topics: Adenosine; Alkenes; Amino Alcohols; Animals; Carbon Isotopes; Chromatography; Chromatography, Ion Exchange; Chromatography, Paper; Humans; Hypoxanthines; Methylation; Milk; Models, Biological; Models, Chemical; Peroxidases; Spectrophotometry; Ultraviolet Rays; Uric Acid; Xanthine Oxidase; Xanthines | 1972 |
The effects of adenine derivatives on urate biosynthesis by isolated chicken liver cells [proceedings].
Topics: Adenine; Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Animals; Bucladesine; Chickens; Cyclic AMP; In Vitro Techniques; Liver; Uric Acid | 1980 |
Adenine nucleotide levels and adenosine metabolism in cultured calvarial bone.
Topics: Adenine Nucleotides; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Bone and Bones; Cells, Cultured; Deoxyadenosines; Dinoprostone; Hypoxanthine; Hypoxanthines; Inosine; Inosine Monophosphate; Mice; Parathyroid Hormone; Prostaglandins E; Uric Acid | 1984 |
[The system of active transport of organic acids in the proximal tubules of rats with hereditary retinal degeneration (Campbell strain)].
Topics: Adenosine; Adenosine Monophosphate; Animals; Bile Acids and Salts; Biological Transport, Active; Disease Models, Animal; Fluoresceins; Hippurates; Kidney Tubules, Proximal; Male; Nephrectomy; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Retinitis Pigmentosa; Uric Acid | 1983 |
[Changes of the acid-base status, serum lactate concentration and purine metabolism in reconstructive arterial surgery].
Topics: Acid-Base Equilibrium; Adenosine; Aorta, Abdominal; Humans; Hypoxanthine; Hypoxanthines; Inosine; Lactates; Lactic Acid; Middle Aged; Purines; Pyruvates; Pyruvic Acid; Uric Acid; Xanthine; Xanthines | 1983 |
Diltiazem administered before or during myocardial ischemia decreases adenine nucleotide catabolism.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Benzazepines; Coronary Circulation; Coronary Disease; Diltiazem; Heart; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Inosine; Male; Myocardium; Perfusion; Phosphocreatine; Rats; Rats, Inbred Strains; Uric Acid; Xanthine; Xanthines | 1984 |
Circadian variations of adenosine level in blood and liver and its possible physiological significance.
Topics: Adenosine; Animals; Circadian Rhythm; Energy Metabolism; Hypoxanthine; Hypoxanthines; Inosine; Liver; Male; Phosphorylation; Purines; Rats; Rats, Inbred Strains; Uric Acid | 1983 |
Effect of adenosine metabolites on methyltransferase reactions in isolated rat livers.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Animals; Hypoxanthines; In Vitro Techniques; Inosine; Kinetics; Liver; Male; Methyltransferases; Perfusion; Rats; S-Adenosylhomocysteine; Uric Acid | 1981 |
Contribution of endothelium and cardiomyocytes to hypoxia-induced adenosine release.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cell Hypoxia; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Energy Metabolism; Heart; Male; Muscle Proteins; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Uric Acid; Vasodilation | 1994 |
Comparison of energy metabolism in rat liver grafts during preservation in University of Wisconsin or Euro-Collins solutions.
Topics: Adenosine; Allopurinol; Animals; Energy Metabolism; Glutathione; Hypertonic Solutions; Hypoxanthine; Hypoxanthines; Inosine; Insulin; Lactates; Liver; Liver Transplantation; Male; Microdialysis; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Sprague-Dawley; Time Factors; Uric Acid; Xanthine; Xanthines | 1995 |
Adenosine metabolism in vivo.
Topics: Adenosine; Animals; Cats; Chromatography, High Pressure Liquid; Female; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Inosine; Male; Uric Acid | 1994 |
Adenosine: a sensitive marker of myocardial ischaemia in man.
Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Circulation; Coronary Disease; Humans; Hypoxanthines; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Regional Blood Flow; Time Factors; Uric Acid | 1994 |
Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery.
Topics: Adenosine; Aged; Aorta; Constriction; Coronary Artery Bypass; Female; Humans; Intraoperative Period; Male; Malondialdehyde; Middle Aged; Myocardium; Postoperative Period; Purines; Tissue Distribution; Uric Acid; Xanthine; Xanthines | 1994 |
Kinetic determination of serum adenosine deaminase.
Topics: 2,6-Dichloroindophenol; Adenosine; Adenosine Deaminase; Autoanalysis; Humans; Hypoxanthine; Hypoxanthines; Kinetics; Pentosyltransferases; Reference Values; Spectrophotometry; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines | 1993 |
Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction.
Topics: Adenosine; Chromatography, High Pressure Liquid; Female; Free Radicals; Humans; Hypoxanthine; Hypoxanthines; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Thrombolytic Therapy; Time Factors; Uric Acid; Xanthine; Xanthines | 1993 |
Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector.
Topics: Adenosine; Animals; Calibration; Chromatography, High Pressure Liquid; Dogs; Extracellular Space; Hypoxanthine; Hypoxanthines; Inosine; Microdialysis; Myocardial Reperfusion Injury; Sensitivity and Specificity; Time Factors; Uric Acid; Xanthine; Xanthines | 1996 |
Temporal variations of adenosine metabolism in human blood.
Topics: 5'-Nucleotidase; Acclimatization; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Kinase; Adenosine Monophosphate; Adenosine Triphosphate; Adenosylhomocysteinase; Adult; Analysis of Variance; Blood Glucose; Circadian Rhythm; Humans; Hydrolases; Hypoxanthine; Inosine; Lactates; Male; Uric Acid | 1996 |
Does adenosine infusion improve oxygenation in term infants with respiratory failure?
Topics: Adenosine; Humans; Infant, Newborn; Respiratory Insufficiency; Uric Acid | 1996 |
Effect of diltiazem on plasma concentrations of oxypurines and uric acid.
Topics: Adenosine; Adult; Cardiovascular Agents; Diltiazem; Female; Guanosine; Humans; Hypoxanthine; Inosine; Male; Myocardial Ischemia; Purines; Uric Acid; Xanthine; Xanthines | 1997 |
Intestinal formation of hypoxanthine and uric acid during endotoxemia.
Topics: Adenosine; Animals; Blood Pressure; Endotoxemia; Hematocrit; Hypoxanthine; Intestinal Mucosa; Leukocyte Count; Male; Oxygen; Platelet Count; Portal System; Rats; Rats, Wistar; Uric Acid | 1997 |
The effects of nucleotide pool on purine production in the postischemic heart.
Topics: Adenosine; Adenosine Triphosphate; Animals; Hypoxanthine; Inosine; Kinetics; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purine Nucleotides; Purines; Rats; Time Factors; Uric Acid; Xanthine | 1998 |
Different mechanism of myocardial nucleotide breakdown during normothermic and hypothermic ischemia.
Topics: Adenosine; Animals; Heart Arrest, Induced; Hypoxanthine; In Vitro Techniques; Inosine; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nucleotides; Rats; Temperature; Time Factors; Uric Acid; Xanthine | 1998 |
Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
Topics: Adenine Nucleotides; Adenosine; Animals; Benzopyrans; Dihydropyridines; Dogs; Extracellular Space; Hemodynamics; Hypoxanthine; Hypoxia; Inosine; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Ischemia; Potassium Channels; Uric Acid; Xanthine | 1998 |
Ethanol's effect on rat pituitary adrenal axis is prevented by purine metabolic pathway inhibitors.
Topics: Adenosine; Adrenocorticotropic Hormone; Animals; Benzocycloheptenes; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Female; In Vitro Techniques; Male; Mercaptopurine; Pituitary-Adrenal System; Purines; Rats; Rats, Wistar; Uric Acid; Xanthine Dehydrogenase | 1999 |
[The central mechanisms regulating the blood circulation in hyperuricemia].
Topics: Adenosine; Animals; Blood Circulation; Brain; Brain Chemistry; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Electrophysiology; Gout; Heart; Male; Rats; Time Factors; Uric Acid | 1999 |
Regional heterogeneities in the production of uric acid from adenosine in the bivascularly perfused rat liver.
Topics: Adenosine; Animals; Hepatic Artery; Hepatic Veins; Infusions, Intravenous; Liver; Male; Oxygen Consumption; Perfusion; Portal Vein; Rats; Rats, Wistar; Uric Acid | 1999 |
A simple high-performance liquid chromatography assay for simultaneous measurement of adenosine, guanosine, and the oxypurine metabolites in plasma.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Guanosine; Humans; Hypoxanthine; Inosine; Purines; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Uric Acid; Xanthine | 2000 |
Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells.
Topics: Adenine; Adenosine; Animals; Disease Models, Animal; Dopamine; Guanine; Guanosine; Hypoxanthine; Neostriatum; Neural Pathways; Neurons; Parkinson Disease; PC12 Cells; Purines; Rats; Substantia Nigra; Uric Acid; Xanthine | 2000 |
Relation between serum uric acid and plasma adenosine levels in twin pregnancies.
Topics: Adenosine; Adult; Female; Humans; Pregnancy; Pregnancy, Multiple; Twins; Uric Acid | 2000 |
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adipose Tissue; Animals; Coronary Disease; Diabetes Mellitus, Type 2; Erythropoiesis; Fatty Acids; Heart Rate; Hematocrit; Humans; Hyperinsulinism; Hypertrophy; Insulin Resistance; Islets of Langerhans; Mitochondria; Mitochondrial ADP, ATP Translocases; Models, Biological; Natriuresis; Obesity; Oxidative Phosphorylation; Renal Circulation; Risk Factors; Sodium; Superoxides; Sympathetic Nervous System; Uric Acid; Vasodilation | 2001 |
Blood purine and energy status in rats with colitis.
Topics: Acetic Acid; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biomarkers; Chromatography, High Pressure Liquid; Colitis; Disease Models, Animal; Energy Metabolism; Hemoglobins; Inosine; Male; Peroxidase; Purines; Rats; Rats, Wistar; Time Factors; Uric Acid | 2001 |
Relation between serum uric acid and plasma adenosine levels in women with preeclampsia.
Topics: Adenosine; Adult; Arteries; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy; Uric Acid | 2001 |
Theacrine (1,3,7,9-tetramethyluric acid) synthesis in leaves of a Chinese tea, kucha (Camellia assamica var. kucha).
Topics: Adenosine; Alkaloids; Beverages; Caffeine; Camellia; Carbon Radioisotopes; Methylation; Molecular Structure; Plant Leaves; Staining and Labeling; Time Factors; Uric Acid | 2002 |
Purinergic dysfunction in mania: an integrative model.
Topics: Adenosine; Adenosine Triphosphate; Animals; Anticonvulsants; Antimanic Agents; Behavior; Bipolar Disorder; Energy Metabolism; Hippocampus; Kindling, Neurologic; Models, Neurological; Neurotransmitter Agents; Protein Kinase C; Rats; Receptors, Purinergic P1; Receptors, Purinergic P2; Second Messenger Systems; Sleep Initiation and Maintenance Disorders; Uric Acid; Xanthines | 2002 |
Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine.
Topics: Adenosine; Adult; Biomarkers; Cell Hypoxia; Humans; Male; Middle Aged; Postpoliomyelitis Syndrome; Sleep Apnea Syndromes; Uric Acid | 2002 |
[Substances derived from Crataegus. VIII. Adenosine, adenine, guanine, uric acid].
Topics: Adenine; Adenosine; Crataegus; Guanine; Plant Extracts; Plants; Uric Acid | 1955 |
HEPATIC CUTANEOUS PORPHYRIA. RESPONSE OF A PATIENT TO TREATMENT WITH ADENOSINE-5-MONOPHOSPHATE.
Topics: Adenine Nucleotides; Adenosine; Blood Chemical Analysis; Glycine; Humans; Levulinic Acids; Liver Diseases; Metabolism; Porphyrias; Porphyrins; Succinates; Uric Acid; Urine | 1964 |
Protective effects of exogenous fructose-1,6-biphosphate during small bowel transplantation in rats.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Bacterial Translocation; Cryopreservation; Cytoprotection; Fructosediphosphates; Glutathione; Hypoxanthine; Insulin; Intestine, Small; Intestines; L-Lactate Dehydrogenase; Male; Organ Preservation Solutions; Oxidative Stress; Raffinose; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Uric Acid; Xanthine | 2004 |
Maternal plasma hypoxanthine levels in nonpreeclamptic twin pregnancies.
Topics: Adenosine; Adult; Female; Humans; Hyperuricemia; Hypoxanthine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Pregnancy, Multiple; Retrospective Studies; Twins; Uric Acid | 2004 |
Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine Diphosphate; Adenosine Triphosphate; Analysis of Variance; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Disease Models, Animal; Endotoxemia; Endotoxins; Energy Metabolism; Female; Lipopolysaccharides; Lung; Pulmonary Artery; Pulmonary Edema; Rabbits; Receptors, Purinergic P1; Respiratory Distress Syndrome; Time Factors; Uric Acid; Vasoconstriction | 2007 |
Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
Topics: 3' Untranslated Regions; Adenosine; Adenosine Deaminase; Animals; Base Sequence; Brain; HeLa Cells; Humans; Inosine; Liver; Mice; MicroRNAs; Molecular Sequence Data; Nucleic Acid Conformation; Organ Specificity; Protein Serine-Threonine Kinases; Ribose-Phosphate Pyrophosphokinase; RNA Editing; RNA Interference; RNA-Binding Proteins; Uric Acid | 2007 |
Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells.
Topics: Adenosine; Animals; Cell Movement; Chronic Disease; Endothelial Cells; Hyperuricemia; Inosine; Ischemia; Ischemic Preconditioning; Kidney; Mice; Mice, Inbred Strains; Oxonic Acid; Stem Cells; Urate Oxidase; Uric Acid | 2007 |
The nadA gene of Aspergillus nidulans, encoding adenine deaminase, is subject to a unique regulatory pattern.
Topics: Adenosine; Aminohydrolases; Aspergillus nidulans; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Metabolic Networks and Pathways; Models, Biological; Protein Binding; Quaternary Ammonium Compounds; Trans-Activators; Transcription Factors; Uric Acid | 2008 |
D-ribose therapy in four Polish patients with adenylosuccinate lyase deficiency: absence of positive effect.
Topics: Adenosine; Adenylosuccinate Lyase; Aminoimidazole Carboxamide; Autistic Disorder; Blood Glucose; Child; Child, Preschool; Creatinine; Female; Growth Disorders; Humans; Poland; Purine-Pyrimidine Metabolism, Inborn Errors; Ribonucleosides; Ribose; Seizures; Severity of Illness Index; Treatment Failure; Uric Acid | 2008 |
Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients.
Topics: Adenosine; Aged; Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Inosine; Male; Middle Aged; Purines; Uric Acid; Xanthine | 2009 |
Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Allopurinol; Analgesics; Animals; Capsaicin; Dose-Response Relationship, Drug; Glutamic Acid; Hot Temperature; Injections, Intraperitoneal; Male; Mice; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Pyrimidines; Triazoles; Uric Acid; Xanthine Oxidase; Xanthines | 2009 |
Influence on energy kinetics and histology of different preservation solutions seen during cold ischemia in the liver.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Allopurinol; Animals; Energy Metabolism; Glutathione; Hypoxanthine; Insulin; Ischemia; Kinetics; Liver; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Reperfusion Injury; Reticulin; Uric Acid; Uridine; Xanthine | 2009 |
High follicular fluid adenosine levels may be pivotal in the metabolism and recycling of adenosine nucleotides in the human follicle.
Topics: Adenine Nucleotides; Adenosine; Adenosine Deaminase; Adenosine Monophosphate; Adenosine Triphosphate; Female; Follicular Fluid; Humans; Hypoxanthine; Inosine Monophosphate; Uric Acid | 2010 |
Conversion of Th17-type into Th2-type inflammation by acetyl salicylic acid via the adenosine and uric acid pathway in the lung.
Topics: Adenosine; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Th17 Cells; Th2 Cells; Uric Acid | 2010 |
Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP.
Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Cell Survival; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Mucosa; Intestines; Male; Mitochondria; Neoplasm Proteins; Rats; Rats, Wistar; Reperfusion Injury; Rotenone; Uncoupling Agents; Uric Acid | 2012 |
A novel method for measuring the ATP-related compounds in human erythrocytes.
Topics: Adenosine; Adenosine Triphosphate; Chromatography, High Pressure Liquid; Erythrocyte Count; Erythrocytes; Homeostasis; Humans; Hydrogen-Ion Concentration; Hypoxanthine; Inosine; Inosine Monophosphate; Sensitivity and Specificity; Uric Acid | 2014 |
Ticagrelor-related gout: An underestimated side effect.
Topics: Adenosine; Gout; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Ticagrelor; Uric Acid | 2015 |
Development and Validation of LC-MS/MS Method for Quantitative Determination of Adenosine, Guanosine, Xanthine and Uric acid in Widely Consumed Vegetables in Thailand.
Topics: Adenosine; Chromatography, High Pressure Liquid; Guanosine; Humans; Plant Extracts; Tandem Mass Spectrometry; Thailand; Uric Acid; Vegetables; Xanthine | 2015 |
Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.
Topics: Adenosine; Aged; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Tumor Cells, Cultured; Uric Acid | 2016 |
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
Topics: Adenosine; Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Ticagrelor; Ticlopidine; Triglycerides; Uric Acid | 2016 |
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Biomarkers; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Up-Regulation; Uric Acid | 2016 |
Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-'Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypoxanthine; Isoproterenol; Rats; Rats, Sprague-Dawley; Uric Acid | 2016 |
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
Topics: Adenosine; Biomarkers; Bipolar Disorder; Humans; Uric Acid | 2017 |
Theacrine: A purine alkaloid from Camellia assamica var. kucha with a hypnotic property via the adenosine system.
Topics: Adenosine; Alkaloids; Animals; Caffeine; Camellia; Drug Synergism; Hippocampus; Male; Mice; Pentobarbital; Pyrimidines; Rats; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazoles; Uric Acid; Xanthines | 2017 |
Simultaneous determination of allantoin and adenosine in human urine using liquid chromatography - UV detection.
Topics: Adenosine; Adult; Allantoin; Chromatography, High Pressure Liquid; Drug Stability; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Uric Acid; Young Adult | 2018 |
Simultaneous determination of cellular adenosine nucleotides, malondialdehyde, and uric acid using HPLC.
Topics: Adenosine; Adult; Chromatography, High Pressure Liquid; Humans; Jurkat Cells; Limit of Detection; Linear Models; Male; Malondialdehyde; Middle Aged; Reproducibility of Results; Saliva; Uric Acid | 2021 |
A modified xanthine oxidase cell model for screening of antihyperuricemic functional compounds.
Topics: Adenosine; Febuxostat; Gout Suppressants; Humans; Hyperuricemia; Hypoxanthines; Peptides; Uric Acid; Xanthine Oxidase | 2022 |